nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—SLCO1C1—Methotrexate—systemic scleroderma	0.0909	0.139	CbGbCtD
Phenytoin—CYP2C8—Mometasone—systemic scleroderma	0.0784	0.12	CbGbCtD
Phenytoin—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0648	0.0994	CbGbCtD
Phenytoin—ALB—Captopril—systemic scleroderma	0.0513	0.0787	CbGbCtD
Phenytoin—ALB—Mycophenolate mofetil—systemic scleroderma	0.0404	0.0619	CbGbCtD
Phenytoin—ABCB1—Lisinopril—systemic scleroderma	0.0358	0.055	CbGbCtD
Phenytoin—CYP2C9—Leflunomide—systemic scleroderma	0.0352	0.054	CbGbCtD
Phenytoin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0325	0.0498	CbGbCtD
Phenytoin—ALB—Prednisone—systemic scleroderma	0.0323	0.0495	CbGbCtD
Phenytoin—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0312	0.0479	CbGbCtD
Phenytoin—ABCB1—Captopril—systemic scleroderma	0.0268	0.0412	CbGbCtD
Phenytoin—ABCC2—Methotrexate—systemic scleroderma	0.026	0.0399	CbGbCtD
Phenytoin—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0211	0.0324	CbGbCtD
Phenytoin—CYP2C19—Prednisone—systemic scleroderma	0.0209	0.0321	CbGbCtD
Phenytoin—ABCB1—Prednisone—systemic scleroderma	0.0169	0.0259	CbGbCtD
Phenytoin—ALB—Methotrexate—systemic scleroderma	0.0162	0.0248	CbGbCtD
Phenytoin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0127	0.0194	CbGbCtD
Phenytoin—CYP3A4—Prednisone—systemic scleroderma	0.0101	0.0155	CbGbCtD
Phenytoin—ABCB1—Methotrexate—systemic scleroderma	0.00847	0.013	CbGbCtD
Phenytoin—CYP2C9—cardial valve—systemic scleroderma	0.0017	0.421	CbGeAlD
Phenytoin—CYP2C18—digestive system—systemic scleroderma	0.000224	0.0553	CbGeAlD
Phenytoin—SCN9A—tendon—systemic scleroderma	0.000203	0.0502	CbGeAlD
Phenytoin—SCN4A—tendon—systemic scleroderma	0.000181	0.0448	CbGeAlD
Phenytoin—SCN9A—lung—systemic scleroderma	0.000178	0.0441	CbGeAlD
Phenytoin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000155	0.000451	CcSEcCtD
Phenytoin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000155	0.000451	CcSEcCtD
Phenytoin—Fatigue—Leflunomide—systemic scleroderma	0.000155	0.00045	CcSEcCtD
Phenytoin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000154	0.000449	CcSEcCtD
Phenytoin—Pruritus—Captopril—systemic scleroderma	0.000154	0.000448	CcSEcCtD
Phenytoin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000154	0.000447	CcSEcCtD
Phenytoin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000447	CcSEcCtD
Phenytoin—Constipation—Leflunomide—systemic scleroderma	0.000154	0.000447	CcSEcCtD
Phenytoin—Infection—Lisinopril—systemic scleroderma	0.000153	0.000446	CcSEcCtD
Phenytoin—SCN1A—lung—systemic scleroderma	0.000153	0.0379	CbGeAlD
Phenytoin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000445	CcSEcCtD
Phenytoin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000153	0.000444	CcSEcCtD
Phenytoin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000152	0.000443	CcSEcCtD
Phenytoin—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000443	CcSEcCtD
Phenytoin—Shock—Lisinopril—systemic scleroderma	0.000152	0.000441	CcSEcCtD
Phenytoin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000151	0.000439	CcSEcCtD
Phenytoin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000151	0.000438	CcSEcCtD
Phenytoin—Tachycardia—Lisinopril—systemic scleroderma	0.000151	0.000438	CcSEcCtD
Phenytoin—Body temperature increased—Azathioprine—systemic scleroderma	0.00015	0.000437	CcSEcCtD
Phenytoin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000434	CcSEcCtD
Phenytoin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000149	0.000434	CcSEcCtD
Phenytoin—Diarrhoea—Captopril—systemic scleroderma	0.000149	0.000433	CcSEcCtD
Phenytoin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000149	0.000433	CcSEcCtD
Phenytoin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000433	CcSEcCtD
Phenytoin—Irritability—Methotrexate—systemic scleroderma	0.000149	0.000432	CcSEcCtD
Phenytoin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000432	CcSEcCtD
Phenytoin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000431	CcSEcCtD
Phenytoin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000148	0.00043	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000148	0.00043	CcSEcCtD
Phenytoin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000148	0.000429	CcSEcCtD
Phenytoin—Mood swings—Methotrexate—systemic scleroderma	0.000148	0.000429	CcSEcCtD
Phenytoin—SCN5A—digestive system—systemic scleroderma	0.000148	0.0365	CbGeAlD
Phenytoin—Nausea—Mometasone—systemic scleroderma	0.000147	0.000428	CcSEcCtD
Phenytoin—Anorexia—Lisinopril—systemic scleroderma	0.000147	0.000428	CcSEcCtD
Phenytoin—Ataxia—Methotrexate—systemic scleroderma	0.000147	0.000426	CcSEcCtD
Phenytoin—Constipation—Mycophenolic acid—systemic scleroderma	0.000147	0.000426	CcSEcCtD
Phenytoin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000426	CcSEcCtD
Phenytoin—Weight decreased—Prednisone—systemic scleroderma	0.000146	0.000424	CcSEcCtD
Phenytoin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000423	CcSEcCtD
Phenytoin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000145	0.000423	CcSEcCtD
Phenytoin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000145	0.00042	CcSEcCtD
Phenytoin—Hypotension—Lisinopril—systemic scleroderma	0.000144	0.000419	CcSEcCtD
Phenytoin—Dizziness—Captopril—systemic scleroderma	0.000144	0.000419	CcSEcCtD
Phenytoin—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000144	0.000418	CcSEcCtD
Phenytoin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000417	CcSEcCtD
Phenytoin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000416	CcSEcCtD
Phenytoin—Urticaria—Leflunomide—systemic scleroderma	0.000143	0.000415	CcSEcCtD
Phenytoin—Body temperature increased—Leflunomide—systemic scleroderma	0.000142	0.000413	CcSEcCtD
Phenytoin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000141	0.00041	CcSEcCtD
Phenytoin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00041	CcSEcCtD
Phenytoin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00041	CcSEcCtD
Phenytoin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00041	CcSEcCtD
Phenytoin—SCN3A—tendon—systemic scleroderma	0.000141	0.0348	CbGeAlD
Phenytoin—Breast disorder—Methotrexate—systemic scleroderma	0.000141	0.000409	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000141	0.000409	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00014	0.000408	CcSEcCtD
Phenytoin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00014	0.000407	CcSEcCtD
Phenytoin—Insomnia—Lisinopril—systemic scleroderma	0.00014	0.000406	CcSEcCtD
Phenytoin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000405	CcSEcCtD
Phenytoin—Paraesthesia—Lisinopril—systemic scleroderma	0.000139	0.000403	CcSEcCtD
Phenytoin—Vomiting—Captopril—systemic scleroderma	0.000139	0.000403	CcSEcCtD
Phenytoin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000401	CcSEcCtD
Phenytoin—Dyspnoea—Lisinopril—systemic scleroderma	0.000138	0.0004	CcSEcCtD
Phenytoin—Rash—Captopril—systemic scleroderma	0.000137	0.000399	CcSEcCtD
Phenytoin—Dermatitis—Captopril—systemic scleroderma	0.000137	0.000399	CcSEcCtD
Phenytoin—Somnolence—Lisinopril—systemic scleroderma	0.000137	0.000399	CcSEcCtD
Phenytoin—Headache—Captopril—systemic scleroderma	0.000137	0.000397	CcSEcCtD
Phenytoin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000396	CcSEcCtD
Phenytoin—Dyspepsia—Lisinopril—systemic scleroderma	0.000136	0.000395	CcSEcCtD
Phenytoin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000135	0.000394	CcSEcCtD
Phenytoin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000393	CcSEcCtD
Phenytoin—Asthma—Methotrexate—systemic scleroderma	0.000135	0.000392	CcSEcCtD
Phenytoin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000391	CcSEcCtD
Phenytoin—Decreased appetite—Lisinopril—systemic scleroderma	0.000134	0.00039	CcSEcCtD
Phenytoin—Eosinophilia—Methotrexate—systemic scleroderma	0.000133	0.000388	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000133	0.000387	CcSEcCtD
Phenytoin—Fatigue—Lisinopril—systemic scleroderma	0.000133	0.000387	CcSEcCtD
Phenytoin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000387	CcSEcCtD
Phenytoin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000386	CcSEcCtD
Phenytoin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000385	CcSEcCtD
Phenytoin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000132	0.000385	CcSEcCtD
Phenytoin—Constipation—Lisinopril—systemic scleroderma	0.000132	0.000384	CcSEcCtD
Phenytoin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000384	CcSEcCtD
Phenytoin—Bradycardia—Prednisone—systemic scleroderma	0.000131	0.000382	CcSEcCtD
Phenytoin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000131	0.00038	CcSEcCtD
Phenytoin—Diarrhoea—Azathioprine—systemic scleroderma	0.00013	0.000378	CcSEcCtD
Phenytoin—Haemoglobin—Prednisone—systemic scleroderma	0.00013	0.000377	CcSEcCtD
Phenytoin—Nausea—Captopril—systemic scleroderma	0.000129	0.000376	CcSEcCtD
Phenytoin—Haemorrhage—Prednisone—systemic scleroderma	0.000129	0.000375	CcSEcCtD
Phenytoin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000375	CcSEcCtD
Phenytoin—Asthenia—Leflunomide—systemic scleroderma	0.000129	0.000375	CcSEcCtD
Phenytoin—Pancytopenia—Methotrexate—systemic scleroderma	0.000128	0.000372	CcSEcCtD
Phenytoin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000127	0.00037	CcSEcCtD
Phenytoin—Pruritus—Leflunomide—systemic scleroderma	0.000127	0.000369	CcSEcCtD
Phenytoin—Connective tissue disorder—Prednisone—systemic scleroderma	0.000127	0.000369	CcSEcCtD
Phenytoin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000367	CcSEcCtD
Phenytoin—Dysuria—Methotrexate—systemic scleroderma	0.000126	0.000366	CcSEcCtD
Phenytoin—Dizziness—Azathioprine—systemic scleroderma	0.000126	0.000366	CcSEcCtD
Phenytoin—SCN3A—lung—systemic scleroderma	0.000124	0.0306	CbGeAlD
Phenytoin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000358	CcSEcCtD
Phenytoin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000123	0.000357	CcSEcCtD
Phenytoin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000123	0.000357	CcSEcCtD
Phenytoin—Diarrhoea—Leflunomide—systemic scleroderma	0.000123	0.000357	CcSEcCtD
Phenytoin—Urticaria—Lisinopril—systemic scleroderma	0.000123	0.000356	CcSEcCtD
Phenytoin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000356	CcSEcCtD
Phenytoin—Body temperature increased—Lisinopril—systemic scleroderma	0.000122	0.000355	CcSEcCtD
Phenytoin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000353	CcSEcCtD
Phenytoin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000121	0.000352	CcSEcCtD
Phenytoin—Vomiting—Azathioprine—systemic scleroderma	0.000121	0.000352	CcSEcCtD
Phenytoin—Pneumonia—Methotrexate—systemic scleroderma	0.000121	0.000351	CcSEcCtD
Phenytoin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00035	CcSEcCtD
Phenytoin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000349	CcSEcCtD
Phenytoin—Drowsiness—Methotrexate—systemic scleroderma	0.00012	0.000349	CcSEcCtD
Phenytoin—Rash—Azathioprine—systemic scleroderma	0.00012	0.000349	CcSEcCtD
Phenytoin—Dermatitis—Azathioprine—systemic scleroderma	0.00012	0.000348	CcSEcCtD
Phenytoin—Headache—Azathioprine—systemic scleroderma	0.000119	0.000346	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000119	0.000346	CcSEcCtD
Phenytoin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000346	CcSEcCtD
Phenytoin—Dizziness—Leflunomide—systemic scleroderma	0.000119	0.000345	CcSEcCtD
Phenytoin—Renal failure—Methotrexate—systemic scleroderma	0.000118	0.000343	CcSEcCtD
Phenytoin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000342	CcSEcCtD
Phenytoin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000117	0.000341	CcSEcCtD
Phenytoin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000117	0.000339	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000339	CcSEcCtD
Phenytoin—Immune system disorder—Prednisone—systemic scleroderma	0.000117	0.000339	CcSEcCtD
Phenytoin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000336	CcSEcCtD
Phenytoin—Sweating—Methotrexate—systemic scleroderma	0.000115	0.000335	CcSEcCtD
Phenytoin—Vomiting—Leflunomide—systemic scleroderma	0.000114	0.000332	CcSEcCtD
Phenytoin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000114	0.000331	CcSEcCtD
Phenytoin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000114	0.00033	CcSEcCtD
Phenytoin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000113	0.000329	CcSEcCtD
Phenytoin—Epistaxis—Methotrexate—systemic scleroderma	0.000113	0.000329	CcSEcCtD
Phenytoin—Rash—Leflunomide—systemic scleroderma	0.000113	0.000329	CcSEcCtD
Phenytoin—Dermatitis—Leflunomide—systemic scleroderma	0.000113	0.000329	CcSEcCtD
Phenytoin—Nausea—Azathioprine—systemic scleroderma	0.000113	0.000328	CcSEcCtD
Phenytoin—Headache—Leflunomide—systemic scleroderma	0.000113	0.000327	CcSEcCtD
Phenytoin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000112	0.000326	CcSEcCtD
Phenytoin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000324	CcSEcCtD
Phenytoin—ABCC2—digestive system—systemic scleroderma	0.000111	0.0274	CbGeAlD
Phenytoin—Asthenia—Lisinopril—systemic scleroderma	0.000111	0.000322	CcSEcCtD
Phenytoin—Pruritus—Lisinopril—systemic scleroderma	0.000109	0.000317	CcSEcCtD
Phenytoin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000109	0.000317	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—systemic scleroderma	0.000108	0.000315	CcSEcCtD
Phenytoin—Rash—Mycophenolic acid—systemic scleroderma	0.000108	0.000314	CcSEcCtD
Phenytoin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000108	0.000314	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—systemic scleroderma	0.000108	0.000313	CcSEcCtD
Phenytoin—ABCB1—blood vessel—systemic scleroderma	0.000108	0.0266	CbGeAlD
Phenytoin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000312	CcSEcCtD
Phenytoin—Headache—Mycophenolic acid—systemic scleroderma	0.000107	0.000312	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—systemic scleroderma	0.000107	0.000311	CcSEcCtD
Phenytoin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000311	CcSEcCtD
Phenytoin—Nausea—Leflunomide—systemic scleroderma	0.000107	0.00031	CcSEcCtD
Phenytoin—Diarrhoea—Lisinopril—systemic scleroderma	0.000106	0.000307	CcSEcCtD
Phenytoin—ABCC2—tendon—systemic scleroderma	0.000105	0.0261	CbGeAlD
Phenytoin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000104	0.000303	CcSEcCtD
Phenytoin—Anaemia—Prednisone—systemic scleroderma	0.000104	0.000302	CcSEcCtD
Phenytoin—Agitation—Prednisone—systemic scleroderma	0.000103	0.0003	CcSEcCtD
Phenytoin—Dizziness—Lisinopril—systemic scleroderma	0.000102	0.000297	CcSEcCtD
Phenytoin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000102	0.000296	CcSEcCtD
Phenytoin—Nausea—Mycophenolic acid—systemic scleroderma	0.000102	0.000296	CcSEcCtD
Phenytoin—Malaise—Prednisone—systemic scleroderma	0.000101	0.000294	CcSEcCtD
Phenytoin—Vertigo—Prednisone—systemic scleroderma	0.000101	0.000293	CcSEcCtD
Phenytoin—Syncope—Prednisone—systemic scleroderma	0.000101	0.000293	CcSEcCtD
Phenytoin—Tinnitus—Methotrexate—systemic scleroderma	0.000101	0.000292	CcSEcCtD
Phenytoin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	9.96e-05	0.00029	CcSEcCtD
Phenytoin—Loss of consciousness—Prednisone—systemic scleroderma	9.87e-05	0.000287	CcSEcCtD
Phenytoin—Vomiting—Lisinopril—systemic scleroderma	9.81e-05	0.000285	CcSEcCtD
Phenytoin—Immune system disorder—Methotrexate—systemic scleroderma	9.74e-05	0.000283	CcSEcCtD
Phenytoin—Rash—Lisinopril—systemic scleroderma	9.73e-05	0.000283	CcSEcCtD
Phenytoin—Convulsion—Prednisone—systemic scleroderma	9.73e-05	0.000283	CcSEcCtD
Phenytoin—Dermatitis—Lisinopril—systemic scleroderma	9.72e-05	0.000283	CcSEcCtD
Phenytoin—Asthenia—Mycophenolate mofetil—systemic scleroderma	9.7e-05	0.000282	CcSEcCtD
Phenytoin—Hypertension—Prednisone—systemic scleroderma	9.7e-05	0.000282	CcSEcCtD
Phenytoin—Chills—Methotrexate—systemic scleroderma	9.67e-05	0.000281	CcSEcCtD
Phenytoin—Headache—Lisinopril—systemic scleroderma	9.67e-05	0.000281	CcSEcCtD
Phenytoin—Pruritus—Mycophenolate mofetil—systemic scleroderma	9.57e-05	0.000278	CcSEcCtD
Phenytoin—Myalgia—Prednisone—systemic scleroderma	9.56e-05	0.000278	CcSEcCtD
Phenytoin—Arthralgia—Prednisone—systemic scleroderma	9.56e-05	0.000278	CcSEcCtD
Phenytoin—CYP2C19—digestive system—systemic scleroderma	9.52e-05	0.0235	CbGeAlD
Phenytoin—Discomfort—Prednisone—systemic scleroderma	9.45e-05	0.000275	CcSEcCtD
Phenytoin—CYP2B6—skin of body—systemic scleroderma	9.31e-05	0.023	CbGeAlD
Phenytoin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.25e-05	0.000269	CcSEcCtD
Phenytoin—Dysgeusia—Methotrexate—systemic scleroderma	9.19e-05	0.000267	CcSEcCtD
Phenytoin—Nausea—Lisinopril—systemic scleroderma	9.17e-05	0.000266	CcSEcCtD
Phenytoin—Anaphylactic shock—Prednisone—systemic scleroderma	9.17e-05	0.000266	CcSEcCtD
Phenytoin—Infection—Prednisone—systemic scleroderma	9.11e-05	0.000265	CcSEcCtD
Phenytoin—Back pain—Methotrexate—systemic scleroderma	9.08e-05	0.000264	CcSEcCtD
Phenytoin—Shock—Prednisone—systemic scleroderma	9.02e-05	0.000262	CcSEcCtD
Phenytoin—Nervous system disorder—Prednisone—systemic scleroderma	8.99e-05	0.000261	CcSEcCtD
Phenytoin—Tachycardia—Prednisone—systemic scleroderma	8.95e-05	0.00026	CcSEcCtD
Phenytoin—Dizziness—Mycophenolate mofetil—systemic scleroderma	8.94e-05	0.00026	CcSEcCtD
Phenytoin—Hyperhidrosis—Prednisone—systemic scleroderma	8.86e-05	0.000258	CcSEcCtD
Phenytoin—Anorexia—Prednisone—systemic scleroderma	8.74e-05	0.000254	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—systemic scleroderma	8.71e-05	0.000253	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—systemic scleroderma	8.67e-05	0.000252	CcSEcCtD
Phenytoin—Vomiting—Mycophenolate mofetil—systemic scleroderma	8.6e-05	0.00025	CcSEcCtD
Phenytoin—Rash—Mycophenolate mofetil—systemic scleroderma	8.53e-05	0.000248	CcSEcCtD
Phenytoin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.52e-05	0.000248	CcSEcCtD
Phenytoin—Headache—Mycophenolate mofetil—systemic scleroderma	8.47e-05	0.000246	CcSEcCtD
Phenytoin—Malaise—Methotrexate—systemic scleroderma	8.46e-05	0.000246	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—systemic scleroderma	8.43e-05	0.000245	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—systemic scleroderma	8.4e-05	0.000244	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	8.35e-05	0.000243	CcSEcCtD
Phenytoin—Insomnia—Prednisone—systemic scleroderma	8.29e-05	0.000241	CcSEcCtD
Phenytoin—Paraesthesia—Prednisone—systemic scleroderma	8.23e-05	0.000239	CcSEcCtD
Phenytoin—Cough—Methotrexate—systemic scleroderma	8.19e-05	0.000238	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—systemic scleroderma	8.13e-05	0.000236	CcSEcCtD
Phenytoin—Dyspepsia—Prednisone—systemic scleroderma	8.07e-05	0.000235	CcSEcCtD
Phenytoin—Nausea—Mycophenolate mofetil—systemic scleroderma	8.03e-05	0.000233	CcSEcCtD
Phenytoin—Arthralgia—Methotrexate—systemic scleroderma	7.99e-05	0.000232	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—systemic scleroderma	7.99e-05	0.000232	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—systemic scleroderma	7.99e-05	0.000232	CcSEcCtD
Phenytoin—Decreased appetite—Prednisone—systemic scleroderma	7.97e-05	0.000232	CcSEcCtD
Phenytoin—Fatigue—Prednisone—systemic scleroderma	7.9e-05	0.00023	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—systemic scleroderma	7.89e-05	0.00023	CcSEcCtD
Phenytoin—Constipation—Prednisone—systemic scleroderma	7.84e-05	0.000228	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—systemic scleroderma	7.72e-05	0.000225	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—systemic scleroderma	7.66e-05	0.000223	CcSEcCtD
Phenytoin—Infection—Methotrexate—systemic scleroderma	7.61e-05	0.000221	CcSEcCtD
Phenytoin—Feeling abnormal—Prednisone—systemic scleroderma	7.55e-05	0.00022	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—systemic scleroderma	7.51e-05	0.000218	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—systemic scleroderma	7.5e-05	0.000218	CcSEcCtD
Phenytoin—CYP3A5—digestive system—systemic scleroderma	7.5e-05	0.0185	CbGeAlD
Phenytoin—CYP2B6—digestive system—systemic scleroderma	7.45e-05	0.0184	CbGeAlD
Phenytoin—Hyperhidrosis—Methotrexate—systemic scleroderma	7.4e-05	0.000215	CcSEcCtD
Phenytoin—CYP2C9—digestive system—systemic scleroderma	7.38e-05	0.0182	CbGeAlD
Phenytoin—Anorexia—Methotrexate—systemic scleroderma	7.3e-05	0.000212	CcSEcCtD
Phenytoin—Urticaria—Prednisone—systemic scleroderma	7.28e-05	0.000212	CcSEcCtD
Phenytoin—Body temperature increased—Prednisone—systemic scleroderma	7.25e-05	0.000211	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—systemic scleroderma	7.16e-05	0.000208	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	6.98e-05	0.000203	CcSEcCtD
Phenytoin—Insomnia—Methotrexate—systemic scleroderma	6.93e-05	0.000201	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—systemic scleroderma	6.88e-05	0.0002	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—systemic scleroderma	6.83e-05	0.000199	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—systemic scleroderma	6.81e-05	0.000198	CcSEcCtD
Phenytoin—Hypersensitivity—Prednisone—systemic scleroderma	6.75e-05	0.000196	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—systemic scleroderma	6.74e-05	0.000196	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—systemic scleroderma	6.66e-05	0.000194	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	6.61e-05	0.000192	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—systemic scleroderma	6.6e-05	0.000192	CcSEcCtD
Phenytoin—Asthenia—Prednisone—systemic scleroderma	6.58e-05	0.000191	CcSEcCtD
Phenytoin—Pruritus—Prednisone—systemic scleroderma	6.48e-05	0.000189	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—systemic scleroderma	6.31e-05	0.000184	CcSEcCtD
Phenytoin—Diarrhoea—Prednisone—systemic scleroderma	6.27e-05	0.000182	CcSEcCtD
Phenytoin—CYP3A5—lung—systemic scleroderma	6.26e-05	0.0155	CbGeAlD
Phenytoin—CYP2B6—lung—systemic scleroderma	6.22e-05	0.0154	CbGeAlD
Phenytoin—Urticaria—Methotrexate—systemic scleroderma	6.09e-05	0.000177	CcSEcCtD
Phenytoin—Dizziness—Prednisone—systemic scleroderma	6.06e-05	0.000176	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—systemic scleroderma	6.06e-05	0.000176	CcSEcCtD
Phenytoin—Vomiting—Prednisone—systemic scleroderma	5.83e-05	0.000169	CcSEcCtD
Phenytoin—Rash—Prednisone—systemic scleroderma	5.78e-05	0.000168	CcSEcCtD
Phenytoin—Dermatitis—Prednisone—systemic scleroderma	5.77e-05	0.000168	CcSEcCtD
Phenytoin—Headache—Prednisone—systemic scleroderma	5.74e-05	0.000167	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—systemic scleroderma	5.64e-05	0.000164	CcSEcCtD
Phenytoin—CYP3A4—digestive system—systemic scleroderma	5.63e-05	0.0139	CbGeAlD
Phenytoin—Asthenia—Methotrexate—systemic scleroderma	5.5e-05	0.00016	CcSEcCtD
Phenytoin—Nausea—Prednisone—systemic scleroderma	5.44e-05	0.000158	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—systemic scleroderma	5.42e-05	0.000158	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—systemic scleroderma	5.24e-05	0.000152	CcSEcCtD
Phenytoin—Dizziness—Methotrexate—systemic scleroderma	5.07e-05	0.000147	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—systemic scleroderma	4.87e-05	0.000142	CcSEcCtD
Phenytoin—Rash—Methotrexate—systemic scleroderma	4.83e-05	0.00014	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—systemic scleroderma	4.83e-05	0.00014	CcSEcCtD
Phenytoin—Headache—Methotrexate—systemic scleroderma	4.8e-05	0.00014	CcSEcCtD
Phenytoin—Nausea—Methotrexate—systemic scleroderma	4.55e-05	0.000132	CcSEcCtD
Phenytoin—ABCB1—digestive system—systemic scleroderma	3.98e-05	0.00984	CbGeAlD
Phenytoin—ABCB1—lung—systemic scleroderma	3.33e-05	0.00822	CbGeAlD
